Subchronic Phencyclidine Treatment Decreases the Number of Dendritic Spine Synapses in the Rat Prefrontal Cortex

Biological Psychiatry

Volumn 60, Issue 6, 2006, Pages 639-644

  Hajszan, Tibor ^a,b   Leranth, Csaba ^a   Roth, Robert H ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

cognition; Phencyclidine; prefrontal cortex; schizophrenia; spine synapses; unbiased stereology

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; PHENCYCLIDINE;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ARTICLE; ASTROCYTE; CELL COUNT; CONTROLLED STUDY; DENDRITIC SPINE; ELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; STEREOMETRY; TREATMENT WITHDRAWAL;

ANIMALS; DENDRITIC SPINES; EXCITATORY AMINO ACID ANTAGONISTS; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; PHENCYCLIDINE; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; SYNAPSES;

EID: 33748757320     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2006.03.015     Document Type: Article

References (40)

1. Akil M., Pierri J.N., Whitehead R.E., Edgar C.L., Mohila C., Sampson A.R., et al. Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects. Am J Psychiatry 156 (1999) 1580-1589
2. Benes F.M., Davidson J., and Bird E.D. Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics. Arch Gen Psychiatry 43 (1986) 31-35
3. Brozoski T.J., Brown R.M., Rosvold H.E., and Goldman P.S. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science 205 (1979) 929-932
4. Cosgrove J., and Newell T.G. Recovery of neuropsychological functions during reduction in use of phencyclidine. J Clin Psychol 47 (1991) 159-169
5. Cotter D., Mackay D., Chana G., Beasley C., Landau S., and Everall I.P. Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. Cereb Cortex 12 (2002) 386-394
6. Freedman R. Schizophrenia. N Engl J Med 349 (2003) 1738-1749
7. Glantz L.A., and Lewis D.A. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity. Arch Gen Psychiatry 54 (1997) 943-952
8. Glantz L.A., and Lewis D.A. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry 57 (2000) 65-73
9. Gundersen H.J., and Jensen E.B. The efficiency of systematic sampling in stereology and its prediction. J Microsc 147 (1987) 229-263
10. Harrison P.J. The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications. Psychopharmacology (Berl) 174 (2004) 151-162
11. Harrison P.J., and Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 10 (2005) 40-68
12. Hertzmann M., Reba R.C., and Kotlyarov E.V. Single photon emission computed tomography in phencyclidine and related drug abuse. Am J Psychiatry 147 (1990) 255-256
13. Hof P.R., and Morrison J.H. The aging brain: morphomolecular senescence of cortical circuits. Trends Neurosci 27 (2004) 607-613
14. Jentsch J.D., Redmond Jr. D.E., Elsworth J.D., Taylor J.R., Youngren K.D., and Roth R.H. Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine. Science 277 (1997) 953-955
15. Jentsch J.D., and Roth R.H. The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 20 (1999) 201-225
16. Jentsch J.D., and Roth R.H. Effects of antipsychotic drugs on dopamine release and metabolism in the central nervous system. In: Lidow M. (Ed). Neurotransmitter Receptors: Actions of Antipsychotic Medications (2000), CRC Press 31-41
17. Jentsch J.D., Taylor J.R., and Roth R.H. Subchronic phencyclidine administration increases mesolimbic dopaminergic system responsivity and augments stress- and psychostimulant-induced hyperlocomotion. Neuropsychopharmacology 19 (1998) 105-113
18. Jentsch J.D., Taylor J.R., and Roth R.H. Phencyclidine model of frontal cortical dysfunction in nonhuman primates. The Neuroscientist 6 (2000) 263-270
19. Jentsch J.D., Tran A., Le D., Youngren K.D., and Roth R.H. Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat. Neuropsychopharmacology 17 (1997) 92-99
20. Lam T.T., and Leranth C. Gonadal hormones act extrinsic to the hippocampus to influence the density of hippocampal astroglial processes. Neuroscience 116 (2003) 491-498
21. Lewis D.A. Neural circuitry approaches to understanding the pathophysiology of schizophrenia. In: Davis K.L., Charney D.S., Coyle J.T., and Nemeroff C. (Eds). Neuropsychopharmacology: The Fifth Generation of Progress (2004), Lippincott Williams & Wilkins, New York 729-743
22. Moghaddam B., and Adams B.W. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science 281 (1998) 1349-1352
23. Nimchinsky E.A., Sabatini B.L., and Svoboda K. Structure and function of dendritic spines. Annu Rev Physiol 64 (2002) 313-353
24. Nyengaard J.R. Stereologic methods and their application in kidney research. J Am Soc Nephrol 10 (1999) 1100-1123
25. Owen A.M., Roberts A.C., Hodges J.R., Summers B.A., Polkey C.E., and Robbins T.W. Contrasting mechanisms of impaired attentional set-shifting in patients with frontal lobe damage or Parkinson's disease. Brain 116 (1993) 1159-1175
26. Owen M.J., O'Donovan M.C., and Harrison P.J. Schizophrenia: a genetic disorder of the synapse?. BMJ 330 (2005) 158-159
27. Park S., and Holzman P.S. Schizophrenics show spatial working memory deficits. Arch Gen Psychiatry 49 (1992) 975-982
28. Prange-Kiel J., Rune G.M., and Leranth C. Median raphe mediates estrogenic effects to the hippocampus in female rats. Eur J Neurosci 19 (2004) 309-317
29. Ridley R.M., Clark B.A., Durnford L.J., and Baker H.F. Stimulus-bound perseveration after frontal ablations in marmosets. Neuroscience 52 (1993) 595-604
30. Shallice T., Burgess P.W., and Frith C.D. Can the neuropsychological case-study approach be applied to schizophrenia?. Psychol Med 21 (1991) 661-673
31. Silva A.J. Molecular and cellular cognitive studies of the role of synaptic plasticity in memory. J Neurobiol 54 (2003) 224-237
32. Sorra K.E., and Harris K.M. Overview on the structure, composition, function, development, and plasticity of hippocampal dendritic spines. Hippocampus 10 (2000) 501-511
33. Stark A.K., Uylings H.B., Sanz-Arigita E., and Pakkenberg B. Glial cell loss in the anterior cingulate cortex, a subregion of the prefrontal cortex, in subjects with schizophrenia. Am J Psychiatry 161 (2004) 882-888
34. Sterio D.C. The unbiased estimation of number and sizes of arbitrary particles using the disector. J Microsc 134 (1984) 127-136
35. Tamminga C.A. Schizophrenia and glutamatergic transmission. Crit Rev Neurobiol 12 (1998) 21-36
36. Tamminga C.A., Buchanan R.W., and Gold J.M. The role of negative symptoms and cognitive dysfunction in schizophrenia outcome. Int Clin Psychopharmacol 13 Suppl 3 (1998) S21-S26
37. Taylor J.R., Elsworth J.D., Roth R.H., Sladek J.R.J., and Redmond Jr. D.E. Cognitive and motor deficits in the acquisition of an object retrieval/detour task in MPTP-treated monkeys. Brain 113 (1990) 617-637
38. Toni N., Buchs P.A., Nikonenko I., Bron C.R., and Muller D. LTP promotes formation of multiple spine synapses between a single axon terminal and a dendrite. Nature 402 (1999) 421-425
39. Wang H.D., and Deutch A.Y. Atypical but not typical antipsychotic drugs reverse dopamine depletion-induced loss of dendritic spines in the prefrontal cortex. Schizophr Bull 31 (2005) 262
40. Weibel E.R. Stereological Methods (1979), Academic Press, London